Spectrum Wealth Advisory Group’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
Other funds holding FBT
Spectrum Wealth Advisory Group's FBT Position: Q3 2026 in Review
Spectrum Wealth Advisory Group sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q3 2026, closing a stake of 16 shares — an estimated $4K sold.
Spectrum Wealth Advisory Group first reported a position in FBT in Q2 2019 and held it in 14 quarters. The position peaked at $4.45M in Q3 2020. 311 funds tracked by Wall St. Rank hold FBT as of Q3 2026.
- Spectrum Wealth Advisory Group reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q3 2026 after selling out during the quarter.
- Spectrum Wealth Advisory Group sold 16 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2026, an estimated $4K.
- Spectrum Wealth Advisory Group first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2019 and held it in 14 quarters.
- Spectrum Wealth Advisory Group's First Trust NYSE Arca Biotechnology Index Fund position peaked at $4.45M in Q3 2020.
- 311 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2026.
Based on Spectrum Wealth Advisory Group's 13F filing for Q3 2026, filed 29 Oct 2026.